BioRestorative Therapies BRTX
NASDAQ BRTX
$2.20 -0.07 (-3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Change in Intangibles (2010 - 2012)

Updated

BioRestorative Therapies' Change in Intangibles was $175,000 in FY2022.

Analysis

BioRestorative Therapies (BRTX) Change in Intangibles (2010 - 2012) Analysis & Trends

  • The FY2022 figure marks the highest annual Change in Intangibles since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -437.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.34 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioRestorative Therapies 976,386.42 -22.96 Mn 17,964.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 1.00 Mn
Dec 31, 2010 1,201.00
API Access

BioRestorative Therapies Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=BRTX&period=max&api_key=YOUR_API_KEY